By the same authors

From the same journal

From the same journal

The social management of biomedical novelty: Facilitating translation in regenerative medicine

Research output: Contribution to journalArticle

Full text download(s)

Author(s)

Department/unit(s)

Publication details

JournalSocial science and medicine
DatePublished - 18 Mar 2016
Volume156
Number of pages7
Pages (from-to)90-97
Original languageEnglish

Abstract

Regenerative medicine (RM) is championed as a potential source of curative treatments for a variety of illnesses, and as a generator of economic wealth and prosperity. Alongside this optimism, however, is a sense of concern that the translation of basic science into useful RM therapies will be laboriously slow due to a range of challenges relating to live tissue handling and manufacturing, regulation, reimbursement and commissioning, and clinical adoption. This paper explores the attempts of stakeholders to overcome these innovation challenges and thus facilitate the emergence of useful RM therapies. The paper uses the notion of innovation niches as an analytical frame. Innovation niches are collectively constructed socio-technical spaces in which a novel technology can be tested and further developed, with the intention of enabling wider adoption. Drawing on primary and secondary data, we explore the motivation for, and the attempted construction of, niches in three domains which are central to the adoption of innovative technologies: the regulatory, the health economic, and the clinical. We illustrate that these niches are collectively constructed via both formal and informal initiatives, and we argue that they reflect wider socio-political trends in the social management of biomedical novelty.

Bibliographical note

© 2016, The Author.

Discover related content

Find related publications, people, projects, datasets and more using interactive charts.

View graph of relations